Pharmaceuticals

Ranbaxy’s Singh bros must pay Daiichi Rs3,500 cr, rules HC

01 Feb 2018

In a petition filed at the Delhi HC, Daiichi had sought to enforce collection of Rs3,500-crore arbitration award it won at a Singapore tribunal in 2016 against Ranbaxy

Varian Medical to buy Australian liver-cancer treatment maker Sirtex for $1.28 bn

31 Jan 2018

Sanofi to buy Belgian biotech company Ablynx for $4.8 bn

29 Jan 2018

Hepatitis C drug may be effective in treatment of Zika-infected adults: study

27 Jan 2018

Celgene to buy experimental gene therapy cancer drug maker Juno Therapeutics for $9 bn

25 Jan 2018

China’s Sinocare in talks to buy J&J’s diabetes care units worth around $4 bn

24 Jan 2018

Sanofi in pact to acquire US biotech haemophila drugs maker Bioverativ for 11.6 bn

22 Jan 2018

Biocon, Sandoz ink global pact for immunology, oncology biosimilar

19 Jan 2018

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally